Mainz Biomed B.V. (MYNZ)

Mainz Biomed B.V. (MYNZ) Income Statement


Mainz Biomed B.V. Income Statement

Last quarter (Q4 2022), Mainz Biomed B.V.'s total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Mainz Biomed B.V.'s net income was $―. See Mainz Biomed B.V.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19
Total Revenue
-$ 529.88K$ 577.35K$ 493.56K$ 281.39K
Cost of Revenue
-$ -347.73K$ 399.73K$ 370.48K$ 342.66K
Gross Profit
-$ 182.15K$ 177.62K$ 123.08K$ -61.27K
Operating Expense
-$ 26.77M$ 9.56M$ 479.39K$ 690.21K
Operating Income
-$ -26.47M$ -9.38M$ -356.30K$ -751.48K
Net Non Operating Interest Income Expense
-$ -159.99K$ -339.17K$ -268.79K$ -201.94K
Other Income Expense
-$ 26.09M$ -1.98M$ 38.20K$ -3.64K
Pretax Income
-$ -26.39M$ -11.70M$ -586.89K$ -957.05K
Tax Provision
--$ 0.00$ 0.00-
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
-$ -52.72M$ -11.69M$ -586.89K$ -957.05K
Basic EPS
-$ -1.86$ -1.62$ -0.05$ -0.08
Diluted EPS
-$ -1.86$ -1.62$ -0.05$ -0.08
Basic Average Shares
-$ 14.16M$ 7.21M$ 11.71M$ 11.71M
Diluted Average Shares
-$ 28.35M$ 7.21M$ 11.71M$ 11.71M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
-$ 26.42M$ 9.96M$ 849.87K$ 1.03M
Net Income From Continuing And Discontinued Operation
-$ -52.72M$ -11.69M$ -586.89K$ -957.05K
Normalized Income
--$ -9.67M$ -594.60K$ -937.64K
Interest Expense
--$ 339.17K$ 176.42K$ 156.87K
-$ -26.18M$ -11.36M$ -410.48K$ -800.19K
-$ -25.80M$ -11.29M$ -350.02K$ -747.15K
Currency in USD

Mainz Biomed B.V. Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis